Skip to content

Beneficient BENF Asset valuation adjustment

Asset valuation adjustment at other companies

Western Alliance Bancorporation logo
Western Alliance BancorporationWAL
-$3.1M-210%
The Travelers Companies logo
The Travelers CompaniesTRV
$31M-8.8%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$170K+103%
CB Financial Services logo
CB Financial ServicesCBFV
$241K-16.6%
C&F Financial logo
C&F FinancialCFFI
$54K-50.0%
Southern Company logo
Southern CompanySO
$359M-8.7%

Other financials

Income statement

See full
Revenue$18.7M+322%
Operating income$3.9M+141%
Net income$19.9M+331%
EPS (diluted)-$0.49+26.5%

Balance sheet

See full
Cash & equivalents$7.9M+87.3%
Total debt$100.3M-16.6%
Total equity-$128.6M-1,002%
Total assets$337.9M-15.5%

Cash flow

See full
Operating cash flow-$9.4M+6.3%
CapEx$96.0K-85.5%
Free cash flow-$9.4M+6.7%

Valuation

See full
Market cap$52.86M+2,018%
Enterprise value$145.33M+40.6%

Profitability

See full
Operating margin548.5%-323pp
Net margin517.9%-235pp
FCF margin156.8%-40.4pp

Returns & leverage

See full
Return on equity-1,647.1%-2,080pp
Debt / equity8.4×-23.8×

Where this comes from

Reported directly by Beneficient in its filing.

Tagged under the XBRL concept ben:BusinessCombinationAssetValuationAdjustment.

The official record: Beneficient’s 10-Q, filed February 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about Beneficient's asset valuation adjustment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Beneficient's asset valuation adjustment?
Beneficient (BENF) reported asset valuation adjustment of $321.9M in Q4 2025.
How has Beneficient's asset valuation adjustment changed year-over-year?
Beneficient's asset valuation adjustment decreased by 0.0% year-over-year, from $321.9M to $321.9M.
What does asset valuation adjustment mean?
Reflects the net change in the carrying value of assets acquired through business combinations to align them with their fair market value at the time of acquisition. This adjustment is essential for understanding the true economic value of acquired portfolios versus their historical book value. It highlights the impact of purchase price allocation on the balance sheet and subsequent amortization or impairment risks.